Recent pinpoint stock value: HCA Healthcare, Inc. (NYSE: HCA)
. Net earnings attributable to HCA Healthcare, Inc. amounted to $1.071 B, or $3.09 per diluted share, contrast to $1.064
Read more. Net earnings attributable to HCA Healthcare, Inc. amounted to $1.071 B, or $3.09 per diluted share, contrast to $1.064
Read moreAlphatec Holdings, Inc. (ATEC) reported just recently preliminary profits results for the 4th quarter and full year ended December 31,
Read moreVBL Therapeutics (VBLT) recently reported financial results for the third quarter ended September 30, 2019, and supplied a business update.
Read moreThird Quarter 2019 Financial Results License earnings: License profits was less than $ 0.1 M for the quarter ended September
Read moreMustang Bio, Inc. (MBIO) reported recently that the first individual has been dosed in a Phase 1 scientific trial to
Read moreNeuroMetrix, Inc. (NURO) just recently stated financial and company highlights for the quarter ended September 30, 2019. The Healthcare sector
Read more” The FDAs acceptance of the FMX103 NDA is another essential turning point for Foamix as the company develops into
Read moreOn Monday, Plus Therapeutics, Inc. (NASDAQ: PSTV) kept in mind an up move of 5.15% in latest trading session with
Read moreThe company lost at -2.80% in past week and declined with -38.10% in one month. During the past three-month duration
Read more